1 |
O. F. Turkoglu, H. Eroglu, O. Okutan, E. Burul, M. F. Sargon, N. Ozer, L. Oner and E. Beskonakli, The efficiency of dexamethasone sodium phosphate-encapsulated chitosan microspheres after cold injury, Surg. Neurol., 64, S2:11-S2:16 (2005)
|
2 |
B. McCormack and G. Gregoriadis, Comparative studies of the fate of free and liposome-entrapped hydroxypropyl-b-cyclodextrin/drug complexes after intravenous injection into rats: implications in drug delivery, Biochim. Biophys. Acta., 1291, 237-244 (1996)
DOI
ScienceOn
|
3 |
G. Hochhaus, H. Derendorf, H. M쉕lmann and J. Barth, A selective LC/RIA for dexamethasone and its prodrug dexamethasone-21-isonicotinate in biological fluids, J. Pharmaceut. Biomed., 9, 761-767 (1991)
DOI
ScienceOn
|
4 |
H. Murakami, M. Kobayashi, H. Takeuchi and Y. Kawashima, Preparation of poly(-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method, Int. J. Pharm., 187, 143-152 (1999)
DOI
ScienceOn
|
5 |
Y. Tauchi, M. Takase, I. Zushida, S. Chono, J. Sato, K. Ito and K. Morimoto, Preparation of a complex of dexame- thasone palmitate-low density lipoprotein and its effect on foam cell formation of murine peritoneal macrophages, J. Pharm. Sci., 88, 709-714 (1999)
DOI
|
6 |
T. Niwa, H. Takeuchi, T. Hino, N. Kunou and Y. Kawashima, Preparations of biodegradable nanospheres of water-soluble and insoluble drugs with D, L-lactide/glycolide copolymer by a novel spontaneous emulsification solvent diffusion method and the drug release behavior, J. Control. Rel., 25, 89-98 (1993)
DOI
ScienceOn
|
7 |
A. Z. Muhlen, C. Schwarz and W. Mehnert, Solid lipid nanoparticles (SLN) for controlled drug delivery-Drug release and release mechanism, Eur. J. Pharm. Biopharm., 45, 149-155 (1998)
DOI
ScienceOn
|
8 |
Ministry of Health and Welfare, The Korea Pharmacopoeia, seventh edition 71-72
|
9 |
S.A. Wissing and O. Kayser, R.H. Solid lipid nanoparticles for parenteral drug delivery Muller, Adv. Drug. Deliver. Rev., 56, 1257-1272 (2004)
DOI
ScienceOn
|
10 |
C. X. Song, V. Labhasetwar, H. Murphy, X. Qu, W. R. Humphrey, R. J. Shebuski and R. J. Levy, Formulation and characterization of biodegradable nanoparticles for intrava-scular local drug delivery, J. Control. Release., 43, 197-212 (1997)
DOI
ScienceOn
|
11 |
H. Fukui, T. Koike, A. Saheki, S. Sonoke and J. Seki, A novel delivery system for amphotericin B with lipid nano-sphere ( ), Int. J. Pharm., 265, 37-45 (2003)
DOI
ScienceOn
|
12 |
M. H. Bonanomi, M. Velvart, M. Stimpel, K. M. Roos, K. Fehr and H. G. Weder, Studies of pharmacokinetics and therapeutic effects of glucocorticoids entrapped in liposomes after intraarticular application in healthy rabbits and in rabbits with antigen-induced arthritis, Rheumatol Int., 7, 203-212 (1987)
DOI
|
13 |
A. R. Mohammed, N. Weston, A. G. A. Coombes, M. Fitzgerald and Y. Perrie, Liposome formulation of poorly water soluble drugs: optimisation of drug loading and ESEM analysis of stability, Int. J. Pharm., 285, 23-34 (2004)
DOI
ScienceOn
|
14 |
A. Sanchez, J. L. Vila-Jato and M. J. Alonso, Development of biodegradable microspheres and nanospheres for the controlled release of cyclosporin A, Int. J. Pharm., 99, 263-273 (1993)
DOI
ScienceOn
|
15 |
G. Cevc and G. Blume, Hydrocortisone and dexamethasone in very deformable drug carriers have increased biological potency, prolonged effect and reduced therapeutic dosage, Biochim. Biophys. Acta., 1663, 61-73 (2004)
DOI
ScienceOn
|